author-photo

Juneko Grilley Olson

University of North Carolina at Chapel Hill

8

Papers

50

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Concurrent definitive immunoradiotherapy for patients with Stage III-IV Head and Neck Cancer and Cisplatin contraindication.

2020 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (9)
A Phase 1b Dose-Escalation Trial of NC-6300 (Nanoparticle Epirubicin) in Patients with Advanced Solid Tumors or Advanced, Metastatic, or Unresectable Soft Tissue Sarcoma.

2020 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (7)
Capecitabine and lapatinib for the first‐line treatment of metastatic/recurrent head and neck squamous cell carcinoma

2016 Cancer
Show All
- Source
- Cite
- Save
Citations (13)
Using the galactose-α-1,3-galactose enzyme-linked immunosorbent assay to predict anaphylaxis in response to cetuximab.

2016 Cancer
Show All
- Source
- Cite
- Save
Citations (13)
Results of a Phase II Trial of Carboplatin, Pemetrexed, and Bevacizumab for the Treatment of Never or Former/Light Smoking Patients With Stage IV Non–Small Cell Lung Cancer

2016 Clinical Lung Cancer
Show All
- Source
- Cite
- Save
Citations (5)
Molecular Testing in 2014: Where We Are

2014
- Juneko Grilley Olson
Show All
- Source
- Cite
- Save
Citations (0)
Six Points of Miscommunication Between Oncologists and Pathologists

2014
- Juneko Grilley Olson
Show All
- Source
- Cite
- Save
Citations (0)